Gretchen Bowker (COO) and Diana Caldwell (CEO) at Pearl Pathways recently presented at IMDMC’s 2018 Reg 101. The workshop took place on Tuesday, June 12, 2018 from 8am to 5pm at the Montage in Indianapolis, Indiana. The workshop was designed for regulatory...
FDA Commissioner Scott Gottlieb, M.D., released a statement on June 12, 2018 discussing new agency efforts. Throughout the statement, Gottlieb acknowledges how biological advancements have led to the development and FDA approval of targeted treatments for patients...
Robert Seevers, Senior Advisor and adjunct Board member at Pearl IRB, will present at the 122nd AFDO Annual Educational Conference occurring in Burlington, VT on June 9-13. As a member of the USP Expert Committee on Packaging, Storage, and Distribution, Robert Seevers...
Pearl Pathways announces the hiring of Nancy Kant as Clinical Services Advisor to support biopharmaceutical and diagnostic life science companies. A skilled biologist, Kant brings over 35 years of experience in the pharmaceutical and diagnostics industries and...
On May 22nd, the House voted to approve a version of “right-to-try” legislation. The bill passed by a vote of 250-169. The bill is intended to help patients with life-threatening conditions, allowing them to access medicines that the Food and Drug Administration (FDA)...
